Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Seelos Therapeutics (SEEL) just unveiled an update.
Seelos Therapeutics, Inc. has announced an upcoming reverse split of its common stock, aiming to make a strategic move in the market. This decision is detailed in their latest press release, which investors might find of significant interest, as it could affect stock value and ownership.
For a thorough assessment of SEEL stock, go to TipRanks’ Stock Analysis page.